Citi analyst Patrick Donnelly raised the firm’s price target on Sotera Health (SHC) to $23 from $21 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHC:
- Sotera Health price target raised to $23 from $21 at Citi
- Sotera Health Announces General Counsel Transition and Retirement
- Sotera Health General Counsel Alex Dimitrief to transition to outside advisor
- Sotera Health sees FY26 adjusted EPS 93c-$1.01, consensus 94c
- Sotera Health reports Q4 adjuest EPS 26c, consensus 24c